Vessel shrinkage as a sign of atherosclerosis progression in type 2 diabetes: A serial intravascular ultrasound analysis

Diabetes

Volumn 58, Issue 1, 2009, Pages 209-214

  Jiménez Quevedo, Pilar ^a   Suzuki, Nobuaki ^b   Corros, Cecilia ^a   Ferrer, Cruz ^a   Angiolillo, Dominick J ^b   Alfonso, Fernando ^a   Hernálndez Antolín, Rosana ^a   Bañuelos, Camino ^a   Escaned, Javier ^a   Fernández, Cristina ^a   Costa, Marco ^b   Macaya, Carlos ^a   Bass, Theodore ^b   Sabaté, Manel ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; GLYCOSYLATED HEMOGLOBIN;

AGED; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERIOGRAPHY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INTRAVASCULAR ULTRASOUND; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; VOLUMETRY; CORONARY BLOOD VESSEL; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; PATHOLOGY;

ATHEROSCLEROSIS; CORONARY VESSELS; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; HUMANS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 63249090765     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db08-0376     Document Type: Article

References (35)

1. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ: Compensatory enlargement of atherosclerotic coronary arteries. N Engl J Med 316:1371-1375, 1987
2. Mintz G, Kent KM, Pichard AD, Satler LF, Popma JJ, Leon MB: Contribution of inadequate remodeling to the development of focal coronary artery stenoses: an intravascular ultrasound study. Circulation 95:1791-1798, 1997
3. Kornowski R, Lansky AJ, Mintz GS, Kent KM, Pichard AD, Satler LF, Bucher TA, Popma JJ, Leon MB: Paradoxic decreases in atherosclerotic plaque mass in insulin-treated diabetic patients. Am, J Cardiol 81:1298-1304, 1998
4. Weissman NJ, Sheris SJ, Chari R, Mendelsohn FO, Anderson WD, Breall JA, Tanguay JF, Diver DJ: Intravascular ultrasonic analysis of plaque characteristics associated with coronary artery remodelling. Am J Cardiol 84:37-40, 1999
5. Britten MB, Zeiher AM, Schachinger V: Effects of cardiovascular risk factors on coronary artery remodeling in patients with mild atherosclerosis. Coron Artery Dis 14:415-422, 2003
6. Hong MK, Park SW, Lee CW, Choi SW, Song JM, Kang DH, Song JK, Kim JJ, Park SJ: Elevated homocysteine levels might be associated with coronary artery remodeling in patients with stable angina: an intravascular ultrasound study. Clin Cardiol 25:225-229, 2002
7. Sabate M, Kay IP, de Feyter PJ, van Domburg RT, Deshpande NV, Ligthart JM, Gijzel AL, Wardeh AJ, Boersma E, Serruys PW: Remodeling of atherosclerotic coronary arteries varies in relation to location and composition of plaque. Am J Cardiol 94:135-140, 1999
8. Vavuranakis M, Stefanadis C, Toutouzas K, Pitsavos C, Spanos V, Toutou- zas P: Impaired compensatory coronary artery enlargement in atherosclerosis contributes to the development of coronary artery stenosis in diabetic patients. Eur Heart J 18:1090-1094, 1997
9. Jensen LO, Thayssen P, Mintz GS, Maeng M, Junker A, Galloe A, Christiansen EH, Hoffmann SK, Pedersen KE, Hansen HS, Hansen KN: Intravas- cular ultrasound assessment of remodelling and reference segment plaque burden in type-2 diabetic patients. Eur Heart J 28:1759-1764, 2007
10. Jimenez-Quevedo P, Sabate M, Angiolillo D, Alfonso F, Hernández-Antolin R, Bañielos C, Bernardo E, Ramirez C, Moreno R, Fernandez C, Escaned J, Macaya C: LDL-cholesterol predicts negative coronary artery remodelling in diabetic patients: an intravascular ultrasound study. Eur Heart J 26:2307-2312, 2005
11. Yoneyama S, Arakawa K, Yonemura A, Isoda K, Nakamura H: Oxidized low-density lipoprotein and high density lipoprotein cholesterol modulate coronary arterial remodelling: an intravascular ultrasound study. Clin Cardiol 26:31-35, 2003
12. Taylor AJ, Burke AP, Farb A, Yousefi P, Malcom GT, Smialek J, Virmani R: Arterial remodeling in the left coronary system. J Am Coll Cardiol 34:760-767, 1999
13. Sabate M, Jiménez-Quevedo P, Angiolillo DJ, Gómez-Hospital JA, Alfonso F, Hernández-Antolin R, Goicolea J, Bañuelos C, Escaned J, Moreno R, Fernández C, Fernández-Aviles F, Macaya C, DIABETES Investigators: Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the Diabetes and Sirolimuseluting Stent (DIABETES) Trial. Circulation 112: 2175-2183, 2005
14. Corros C, Sabate M, Jimenez-Quevedo P, Alfonso F, Angiolillo D, Gomez- Hospital JA, Moreu J, Pinar E, Hernandez-Antolin R, Escaned J, Costa M, Moreno R, Banuelos C, Macaya C: Efficacy of paclitaxel-eluting stent implantation in diabetic patients with de novo coronary stenoses: final results of the DIABETES II trial (Abstract). Am J Cardiol 96 (Suppl. S):41H, 2005
15. Sabate M, Ferrer MC, Jimenez-Quevedo P, Gomez-Hospital JA, Costa M, Angiolillo DJ, Pinar E, Alfonso F, Hernandez-Antolin R, Escaned J, Moreno R, Banuelos C, Bass T, Macaya C: Efficacy of tacrolimus-eluting stent to prevent restenosis in diabetic patients: final results of the DIABETES-3 trial (Abstract). Am J Cardiol 98 (Suppl. 8A):117M, 2006
16. Abizaid A, Albertal M, Costa MA, Abizaid AS, Staico R, Feres F, Mattos LA, Sousa AG, Moses J, Kipshidize N, Roubin GS, Mehran R, New G, Leon MB, Sousa JE: First human experience with the 17betaestradiol-eluting stent: the Estrogens and Stents to Eliminate Restenosis (EASTER) trial. JAm Coll Cardiol 43:1118-1121, 2004
17. Mintz G, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, Pinto FJ, Rosenfield K, Siegel RJ, Tuzcu EM, Yock PG: American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). J Am Coll Cardiol 37:1479-1482, 2001
18. Sipahi I, Tuzcu EM, Schoenhagen P, Nicholls SJ, Crowe T, Kapadia S, Nissen SE: Static and serial assessments of coronary arterial remodeling are discordant: an intravascular ultrasound analysis from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial. Am Heart J 152:544-550, 2006
19. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative centrifuge. Clin Chem 18:499-502, 1972
20. McCullagh P, Nelder JA: Generalized Linear Models. 2nd ed. London, Chapman and Hall, 1989 21. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA: Impaired endothelium-dependent vasodilation in patients with insulin- dependent diabetes mellitus. Circulation 88:2510-2516, 1993
21. Cohen RA: Dysfunction of vascular endothelium in diabetes mellitus. Circulation 87 (Suppl. V):V67-V76, 1993
22. Neunteufl T, Katzenschlager R, Hassan A, Klaar U, Schwarzacher S, Glogar D, Bauer P, Weidinger F: Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis 129:111-118, 1997
23. Tronc F, Wassef M, Esposito B, Henrion D, Glagov S, Tedgui A: Role of NO in flow-induced remodeling of the rabbit common carotid artery. Arterio-scler Thromb Vasc Biol 16:1256-1262, 1996
24. Abizaid A, Kornowski R, Mintz GS, Hong MK, Abizaid AS, Mehran R, Pichard AD, Kent KM, Satler LF, Wu H, Popma JJ, Leon MB: The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 32:584-589, 1998
25. Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, Wright AD, Turner RC, Holman RR: Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes UKPDS
26. 36: prospective observational study. BMJ 321:412-419, 2000
27. Pu LJ, Lu L, Shen WF, Zhang Q, Zhang RY, Zhang JS, Hu J, Yang ZK, Ding FH, Chen QJ, Shen J, Fang DH, Lou S: Increased serum glycated albumin level is associated with the presence and severity of coronary artery disease in type 2 diabetic patients. Circ J 71:1067-1073, 2007
28. Corpus RA, George PB, House JA, Dixon SR, Ajluni SC, Devlin WH, Timmis GC, Balasubramaniam M, O'Neill WW: Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention. J Am Coll Cardiol 43:8-14, 2004
29. Mazeika P, Prasad N, Bui S, Seidelin PH: Predictors of angiographic restenosis after coronary intervention in patients with diabetes mellitus. Am Heart J 145:1013-1021, 2003
30. Anand DV, Lim E, Darko D, Bassett P, Hopkins D, Lipkin D, Corder R, Lahiri A: Determinants of progression of coronary artery calcification in type 2 diabetes role of glycemic control and inflammatory/vascular calcification markers. J Am Coll Cardiol 50:2218-2225, 2007
31. Basta G, Schmidt AM, De Caterina R: Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 63:582-592, 2004
32. Yan SF, Ramasamy R, Naka Y, Schmidt AM: Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond. Circ Res 93:1159-1169, 2003
33. Ingelsson E, Schaefer EJ, Contois JH, McNamara JR, Sullivan L, Keyes MJ, Pencina MJ, Schoonmaker C, Wilson PW, D'Agostino RB, Vasan RS: Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA 298:776-785, 2007
34. Jensen LO, Thayssen P, Mintz GS, Carlier SG, Pedersen KE, Haghfelt T: Effect of simvastatin on coronary lesion site remodeling: a serial intravas- cular ultrasound study. Cardiology 106:256-263, 2006
35. Schoenhagen P, Tuzcu EM, Apperson-Hansen C, Wang C, Wolski K, Lin S, Sipahi I, Nicholls SJ, Magyar WA, Loyd A, Churchill T, Crowe T, Nissen SE:Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial Circulation 113:2826-2834, 2006